The latest announcement is out from Oramed Pharm ( ($ORMP) ). Oramed Pharmaceuticals Inc. has restructured its financial relationship with Scilex Holding Company by entering into new agreements that include
The latest announcement is out from Oramed Pharm ( ($ORMP) ). Oramed Pharmaceuticals Inc. has restructured its financial relationship with Scilex Holding Company by entering into new agreements that include
Oramed Pharmaceuticals (ORMP) announced the execution of definitive agreements for the restructuring of a portion of its existing Senior Secured Promissory Note from Scilex Holding Company (SCLX). Oramed, affiliates of
H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on Oramed Pharm (ORMP – Research Report) today. The company’s shares closed last Friday at $2.35. According to TipRanks, Selvaraju is
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: DiaMedica Therapeutics (DMAC), 2,400% surge in interest Wave Life
Oramed Pharmaceuticals announced that its Board of Directors has authorized a common stock repurchase plan allowing for the buy-back of up to $20M in maximum value of its common stock